Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 19, 2017 Filed Jun 21, 2017 19:43 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 117 | $82.34 | $9,633.78 |
DisclosureSEC source: 0000059478-17-000170 · wf-form4_149807421705156.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,656 Read SEC document |
| June 14, 2017 Filed Dec 5, 2017 22:43 UTC |
Ricks David ADirector · President & CEO
|
GiftCommon Stock | 25 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000243 · wf-form4_151251380489040.xml · nonDerivative · entry 3 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,433 Read SEC document |
| June 13, 2017 Filed Jan 30, 2018 21:03 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
GiftCommon Stock | 2,091 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000016 · wf-form5_151734619929734.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,950 Read SEC document |
| June 13, 2017 Filed Jan 30, 2018 21:06 UTC |
Crowe Maria APresident, Mfg. Operations
|
GiftCommon Stock | 125 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000018 · wf-form5_151734640031769.xml · nonDerivative · entry 1 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,456 Read SEC document |
| June 12, 2017 Filed Jun 13, 2017 20:10 UTC |
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERM
|
SaleCommon Stock | 1,900 | $80.78 | $153,482.00 |
DisclosureSEC source: 0000059478-17-000161 · wf-form4_149738464100946.xml · nonDerivative · entry 1 Barnes Melissa S · CIK 0001566364 · Chief Eth/Cmpl Ofcr & SVP, ERM 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,041 Read SEC document |
| June 09, 2017 Filed Jun 9, 2017 20:15 UTC |
Harrington Michael JSenior VP and General Counsel
|
SaleCommon Stock | 22,833 | $79.97 | $1,825,955.01 |
DisclosureSEC source: 0000059478-17-000159 · wf-form4_149703930291114.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,056 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 2, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $79.70 to $80.27. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 25, 2017 Filed Dec 13, 2017 20:09 UTC |
LECHLEITER JOHN Cformer director
|
GiftCommon Stock | 387,058 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000253 · wf-form4_151319578611273.xml · nonDerivative · entry 3 LECHLEITER JOHN C · CIK 0001209281 · former director 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 436,160 F1 · balance_after: Reflects number of shares owned as of May 31, 2017. F2 · ownership.nature: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| May 25, 2017 Filed Dec 13, 2017 20:09 UTC |
LECHLEITER JOHN Cformer director
|
GiftCommon Stock | 387,058 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000253 · wf-form4_151319578611273.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · former director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436,161 F1 · balance_after: Reflects number of shares owned as of May 31, 2017. Read SEC document |
| May 22, 2017 Filed Dec 13, 2017 20:01 UTC |
Simmons Jeffrey NSVP&Pres. Elanco Animal Health
|
GiftCommon Stock | 6,390 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000249 · wf-form4_151319528674708.xml · nonDerivative · entry 2 Simmons Jeffrey N · CIK 0001479079 · SVP&Pres. Elanco Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,132 Read SEC document |
| May 15, 2017 Filed May 17, 2017 18:42 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 120 | $80.30 | $9,636.00 |
DisclosureSEC source: 0000059478-17-000148 · wf-form4_149504654011366.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,525 Read SEC document |
| May 15, 2017 Filed May 17, 2017 18:47 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 136 | $80.30 | $10,920.80 |
DisclosureSEC source: 0000059478-17-000150 · wf-form4_149504682842264.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,980 Read SEC document |
| May 05, 2017 Filed Dec 5, 2017 22:43 UTC |
Ricks David ADirector · President & CEO
|
GiftCommon Stock | 357 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000243 · wf-form4_151251380489040.xml · nonDerivative · entry 4 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,076 Read SEC document |
| May 04, 2017 Filed May 8, 2017 19:44 UTC |
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSA
|
SaleCommon Stock | 25,000 | $82.76 | $2,069,000.00 |
DisclosureSEC source: 0000059478-17-000144 · wf-form4_149427264277920.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · SVP&Pres, LillyDiab & LillyUSA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,217 F1 · price: This transaction was executed in multiple trades at prices ranging from $82.67 to $82.86. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 04, 2017 Filed Dec 13, 2017 20:09 UTC |
LECHLEITER JOHN Cformer director
|
GiftCommon Stock | 11,072 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000253 · wf-form4_151319578611273.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · former director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823,219 Read SEC document |
| May 01, 2017 Filed May 8, 2017 19:53 UTC |
Shaw ChristiSVP and Pres., Lilly Bio-Meds
|
GrantRestricted Stock Unit · Derivative | 27,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000146 · wf-form4_149427319028934.xml · derivative · entry 1 Shaw Christi · CIK 0001702473 · SVP and Pres., Lilly Bio-Meds 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. F2 · derivative.exercise_date: The restricted stock units vest in two equal installments on May 1, 2018 and May 1, 2019. F2 · derivative.expiration_date: The restricted stock units vest in two equal installments on May 1, 2018 and May 1, 2019. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 18:35 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 133 | $82.38 | $10,956.54 |
DisclosureSEC source: 0000059478-17-000121 · wf-form4_149262691663841.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,844 Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 18:41 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 117 | $82.38 | $9,638.46 |
DisclosureSEC source: 0000059478-17-000123 · wf-form4_149262726830174.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,405 Read SEC document |
| March 30, 2017 Filed Mar 31, 2017 15:11 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 210,000 | $84.67 | $17,781,540.00 |
DisclosureSEC source: 0001209191-17-023790 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,690,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.51 to $84.95, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 20:54 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 130 | $83.73 | $10,884.90 |
DisclosureSEC source: 0000059478-17-000110 · wf-form4_149021603793084.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,711 Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 21:01 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 115 | $83.73 | $9,628.95 |
DisclosureSEC source: 0000059478-17-000112 · wf-form4_149021648256236.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,288 Read SEC document |
| February 27, 2017 Filed Feb 28, 2017 18:21 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 225,000 | $83.06 | $18,688,950.00 |
DisclosureSEC source: 0001209191-17-015113 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,900,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.68 to $83.38, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:34 UTC |
LUCIANO JUAN RDirector
|
GrantCommon Stock | 120 | $80.36 | $9,643.20 |
DisclosureSEC source: 0000059478-17-000102 · wf-form4_148789283294059.xml · nonDerivative · entry 1 LUCIANO JUAN R · CIK 0001455792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,160 Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:38 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 136 | $80.36 | $10,928.96 |
DisclosureSEC source: 0000059478-17-000104 · wf-form4_148789309369708.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,362 Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 20:45 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 230,000 | $80.27 | $18,462,790.00 |
DisclosureSEC source: 0001209191-17-012604 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,125,804 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.09 to $80.56, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| February 08, 2017 Filed Jan 30, 2018 21:10 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 38,292 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000020 · wf-form5_151734660054829.xml · nonDerivative · entry 2 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · by wife Disclosed balance after: 403,951 F1 · ownership.direct: Reporting person disclaims beneficial ownership of these shares. Read SEC document |
| February 08, 2017 Filed Jan 30, 2018 21:10 UTC |
Rice Derica WEVP-Global Services and CFO
|
GiftCommon Stock | 38,292 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-18-000020 · wf-form5_151734660054829.xml · nonDerivative · entry 1 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 15:02 UTC |
Zulueta Alfonso GSVP& Pres., Emerging Markets
|
SaleCommon Stock | 15,000 | $77.66 | $1,164,900.00 |
DisclosureSEC source: 0000059478-17-000091 · wf-form4_148656613305978.xml · nonDerivative · entry 1 Zulueta Alfonso G · CIK 0001596336 · SVP& Pres., Emerging Markets 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,583 Read SEC document |
| February 03, 2017 Filed Feb 3, 2017 22:20 UTC |
Rice Derica WEVP-Global Services and CFO
|
SaleCommon Stock | 3,892 | $77.47 | $301,513.24 |
DisclosureSEC source: 0000059478-17-000089 · wf-form4_148616041253502.xml · nonDerivative · entry 4 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,292 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 8, 2016. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 20:22 UTC |
Zakrowski Donald AChief Accounting Officer
|
SaleCommon Stock | 2,000 | $77.52 | $155,040.00 |
DisclosureSEC source: 0000059478-17-000086 · wf-form4_148615333655028.xml · nonDerivative · entry 1 Zakrowski Donald A · CIK 0001561539 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 886 Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 22:20 UTC |
Rice Derica WEVP-Global Services and CFO
|
SaleCommon Stock | 7,270 | $76.97 | $559,571.90 |
DisclosureSEC source: 0000059478-17-000089 · wf-form4_148616041253502.xml · nonDerivative · entry 3 Rice Derica W · CIK 0001359067 · EVP-Global Services and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,184 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 8, 2016. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 20:38 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,243 | $78.04 | $253,070.75 |
DisclosureSEC source: 0001209191-17-007037 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,355,804 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.12, inclusive. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 20:38 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 216,757 | $77.34 | $16,763,769.62 |
DisclosureSEC source: 0001209191-17-007037 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,359,047 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.00 to $77.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:35 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000062 · wf-form4_148615054513386.xml · derivative · entry 4 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,244 shares Expires 2017-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:35 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Tax withholdingCommon Stock | 4,810 | $77.03 | $370,514.30 |
DisclosureSEC source: 0000059478-17-000062 · wf-form4_148615054513386.xml · nonDerivative · entry 2 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,217 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:35 UTC |
Conterno Enrique ASr. VP & Pres., Lilly Diabetes
|
Exercise / conversionCommon Stock | 10,244 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000062 · wf-form4_148615054513386.xml · nonDerivative · entry 1 Conterno Enrique A · CIK 0001476151 · Sr. VP & Pres., Lilly Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,027 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:41 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 8,195 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000064 · wf-form4_148615088574933.xml · derivative · entry 3 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,195 shares Expires 2017-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:41 UTC |
Crowe Maria APresident, Mfg. Operations
|
Tax withholdingCommon Stock | 3,732 | $77.03 | $287,475.96 |
DisclosureSEC source: 0000059478-17-000064 · wf-form4_148615088574933.xml · nonDerivative · entry 2 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,581 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:41 UTC |
Crowe Maria APresident, Mfg. Operations
|
Exercise / conversionCommon Stock | 8,195 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000064 · wf-form4_148615088574933.xml · nonDerivative · entry 1 Crowe Maria A · CIK 0001538603 · President, Mfg. Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:58 UTC |
Harrington Michael JSenior VP and General Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 9,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000068 · wf-form4_148615189052303.xml · derivative · entry 4 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,732 shares Expires 2017-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:58 UTC |
Harrington Michael JSenior VP and General Counsel
|
Tax withholdingCommon Stock | 4,543 | $77.03 | $349,947.29 |
DisclosureSEC source: 0000059478-17-000068 · wf-form4_148615189052303.xml · nonDerivative · entry 2 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,889 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:58 UTC |
Harrington Michael JSenior VP and General Counsel
|
Exercise / conversionCommon Stock | 9,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000068 · wf-form4_148615189052303.xml · nonDerivative · entry 1 Harrington Michael J · CIK 0001566340 · Senior VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,432 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:53 UTC |
Fry Stephen FSVP, HR & Diversity
|
Exercise / conversionRestricted Stock Unit · Derivative | 7,683 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000066 · wf-form4_148615157396403.xml · derivative · entry 4 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,683 shares Expires 2017-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:53 UTC |
Fry Stephen FSVP, HR & Diversity
|
Tax withholdingCommon Stock | 3,608 | $77.03 | $277,924.24 |
DisclosureSEC source: 0000059478-17-000066 · wf-form4_148615157396403.xml · nonDerivative · entry 2 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,944 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 19:53 UTC |
Fry Stephen FSVP, HR & Diversity
|
Exercise / conversionCommon Stock | 7,683 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000066 · wf-form4_148615157396403.xml · nonDerivative · entry 1 Fry Stephen F · CIK 0001513324 · SVP, HR & Diversity 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 20:01 UTC |
LECHLEITER JOHN CDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 46,097 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000070 · wf-form4_148615206471252.xml · derivative · entry 7 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 46,097 shares Expires 2017-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 20:01 UTC |
LECHLEITER JOHN CDirector
|
Tax withholdingCommon Stock | 21,696 | $77.03 | $1,671,242.88 |
DisclosureSEC source: 0000059478-17-000070 · wf-form4_148615206471252.xml · nonDerivative · entry 2 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 834,291 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 20:01 UTC |
LECHLEITER JOHN CDirector
|
Exercise / conversionCommon Stock | 46,097 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000070 · wf-form4_148615206471252.xml · nonDerivative · entry 1 LECHLEITER JOHN C · CIK 0001209281 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 855,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 20:04 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Exercise / conversionRestricted Stock Unit · Derivative | 15,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000072 · wf-form4_148615226227376.xml · derivative · entry 4 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,366 shares Expires 2017-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 20:04 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Tax withholdingCommon Stock | 7,215 | $77.03 | $555,771.45 |
DisclosureSEC source: 0000059478-17-000072 · wf-form4_148615226227376.xml · nonDerivative · entry 2 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,153 Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 20:04 UTC |
Lundberg Jan MEVP,Science&Tech and Pres. LRL
|
Exercise / conversionCommon Stock | 15,366 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-17-000072 · wf-form4_148615226227376.xml · nonDerivative · entry 1 Lundberg Jan M · CIK 0001480120 · EVP,Science&Tech and Pres. LRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,368 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.